{"id":2868,"date":"2024-10-11T06:25:44","date_gmt":"2024-10-11T06:25:44","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/impurities-residual-solvents-in-new-veterinary-medicinal-products-active-substances-and-excipients-revision-2\/"},"modified":"2024-10-23T13:18:26","modified_gmt":"2024-10-23T13:18:26","slug":"impurities-residual-solvents-in-new-veterinary-medicinal-products-active-substances-and-excipients-revision-2","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/es\/guidline\/impurities-residual-solvents-in-new-veterinary-medicinal-products-active-substances-and-excipients-revision-2\/","title":{"rendered":"Impurezas: Disolventes residuales en nuevos medicamentos veterinarios, sustancias activas y excipientes (Revisi\u00f3n en la Fase 9)"},"content":{"rendered":"<p>VICH GL18(R) (Calidad &#8211; Impurezas: Disolventes residuales) Julio 2011 &#8211; Implementado en junio de 2012<\/p>\n","protected":false},"menu_order":153,"template":"","meta":[],"guideline_category":[245],"class_list":["post-2868","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-quality-impurities-es"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline\/2868","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/media?parent=2868"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/es\/wp-json\/wp\/v2\/guideline_category?post=2868"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}